CROWDNCT06908070
Chemoradiotherapy With Surgery Followed by Consolidation Durvalumab
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 1 with changes below, 1 re-verified with no change.
- Study First Submitted
Endpoints
Primary
The rates of severe surgical morbidity and mortality
Timeframe: Within 90-days of surgery
Percentage of patients with high-grade treatment-related adverse events
Timeframe: Within 90-days of surgery
Proportion of patients proceeding to durvalumab consolidation after surgery
Timeframe: Within 2 months
Secondary (2)
R0 rate
DFS at 2 years
Arms and interventions
Chemoradiotherapy plus surgery and immunotherapyExperimental
Chemoradiotherapy followed by surgery and consolidation durvalumab
Drugs: Consolidation durvalumab
Sites
1 site in 1 country
- Amsterdam UMC, location VU Medical centerAmsterdam, Netherlands